AU2002352303A1 - Enhancing the availability of minerals by using biologically active peptides - Google Patents

Enhancing the availability of minerals by using biologically active peptides

Info

Publication number
AU2002352303A1
AU2002352303A1 AU2002352303A AU2002352303A AU2002352303A1 AU 2002352303 A1 AU2002352303 A1 AU 2002352303A1 AU 2002352303 A AU2002352303 A AU 2002352303A AU 2002352303 A AU2002352303 A AU 2002352303A AU 2002352303 A1 AU2002352303 A1 AU 2002352303A1
Authority
AU
Australia
Prior art keywords
minerals
availability
enhancing
biologically active
active peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002352303A
Inventor
Riitta Korpela
Annika Mayra-Makinen
Mirkka Narva
Olli Tossavainen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valio Oy
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valio Oy filed Critical Valio Oy
Publication of AU2002352303A1 publication Critical patent/AU2002352303A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Dairy Products (AREA)
AU2002352303A 2002-02-25 2002-12-20 Enhancing the availability of minerals by using biologically active peptides Abandoned AU2002352303A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20020360 2002-02-25
FI20020360A FI112031B (en) 2002-02-25 2002-02-25 New use of a biologically active product
PCT/FI2002/001051 WO2003070267A1 (en) 2002-02-25 2002-12-20 Enhancing the availability of minerals by using biologically active peptides

Publications (1)

Publication Number Publication Date
AU2002352303A1 true AU2002352303A1 (en) 2003-09-09

Family

ID=8563317

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002352303A Abandoned AU2002352303A1 (en) 2002-02-25 2002-12-20 Enhancing the availability of minerals by using biologically active peptides

Country Status (6)

Country Link
EP (1) EP1485119A1 (en)
JP (1) JP4242293B2 (en)
AU (1) AU2002352303A1 (en)
FI (1) FI112031B (en)
RU (1) RU2004128448A (en)
WO (1) WO2003070267A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006004105A1 (en) * 2004-07-05 2006-01-12 Calpis Co., Ltd. Method of producing peptide mixture, method of producing fermented milk containing antihypertensive peptide and method of producing antihypertensive peptide preparation
PL1820851T3 (en) * 2006-02-20 2012-07-31 Gervais Danone Sa Non-lactose fermenting Lactobacillus helveticus
US20090111758A1 (en) * 2006-05-15 2009-04-30 Valio Ltd. Use of therapeutically useful peptides
FI122531B (en) * 2009-09-30 2012-03-15 Valio Oy Cheese and process for making them
CN103221531B (en) * 2010-11-09 2018-03-16 朝日集团控股株式会社 Lactobacillus helveticus with high protein hydrolysing activity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ183858A (en) * 1976-12-17 1979-10-25 Ashmead Hh Polyvalent metal proteinates as food additives
HUT52962A (en) * 1988-03-04 1990-09-28 Sandoz Ag Process for production of medical compositions eliminating bone-absorption and promoting forming of bones
JP3488722B2 (en) * 1992-03-04 2004-01-19 カルピス株式会社 Calcium absorption promoting activator and method for producing the same
JP2782142B2 (en) 1992-07-23 1998-07-30 カルピス株式会社 Angiotensin converting enzyme inhibitor and method for producing the same
US6214800B1 (en) * 1995-10-25 2001-04-10 Senju Pharmaceutical Co., Ltd. Angiogenesis inhibitor
KR100221124B1 (en) * 1996-09-23 1999-10-01 한상기 Novel casein and preparing method thereof
JP3028411B2 (en) 1997-09-26 2000-04-04 カルピス株式会社 Lactobacillus helveticus lactic acid bacteria with high tripeptide productivity
FI113741B (en) * 1999-11-01 2004-06-15 Valio Oy Process for the preparation of a product containing peptides with antihypertensive effect
AU2001245547A1 (en) * 2000-03-13 2001-09-24 Monsanto Technology Llc Process for producing peptide sequences possessing anti-hypertension activity

Also Published As

Publication number Publication date
JP2005517424A (en) 2005-06-16
EP1485119A1 (en) 2004-12-15
WO2003070267A1 (en) 2003-08-28
FI20020360A0 (en) 2002-02-25
JP4242293B2 (en) 2009-03-25
RU2004128448A (en) 2005-04-20
FI112031B (en) 2003-10-31

Similar Documents

Publication Publication Date Title
AU2003272069A1 (en) Novel floating dosage form
AU2003280511A1 (en) Vibrator
AU2003289742A1 (en) Stable therapeutic proteins
AU2003201727A1 (en) Recombinant protein expression
AU2003290563A1 (en) Leptin-related peptides
AU2003213997A1 (en) Biologically active copper-organic agents
GB2411404B (en) Biologically active peptide conjugates
GB0205347D0 (en) Biologically active complex
AU2002352303A1 (en) Enhancing the availability of minerals by using biologically active peptides
AU2003261801A1 (en) Novel depsipeptide compound
GB0218977D0 (en) Polypeptide
AU2003238178A1 (en) Pancreas-specific proteins
AU2003202694A1 (en) Torero protein
GB0223193D0 (en) Polypeptide
GB0202275D0 (en) Peptide
AU2003302330A1 (en) Antimicrobial peptides
AU2003278718A1 (en) Stars-a muscle-specification-binding protein
AU2003270055A1 (en) Neurotransmission-associated proteins
TWI318631B (en) Biologically active peptides
GB0208925D0 (en) Polypeptide
AU2003300785A1 (en) Carbohydrate-associated proteins
GB0210746D0 (en) Peptide
AU2003219326A1 (en) Lightweight levelling material
AU2003254865A1 (en) Akt2-BINDING PROTEIN
AU2003295760A1 (en) Organelle-associated proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase